Category: Gene Therapy
Global Gene Therapy
-
Viral Vector Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The global market for viral vector manufacturing has witnessed remarkable growth over the past decade. In 2024, the market recorded revenue of US$ 800 million, and it is projected to reach a valuation of US$ ... Read More
-
Rare Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... North America Leads with a Dominant Market Share The global rare disease treatment market is on an upward trajectory, with the genetic diseases segment expected to maintain its dominance in the coming years, according to ... Read More
-
Cell & Gene Therapy Manufacturing Services Global Market Report 2024
... Application: Commercial Manufacturing; Clinical Manufacturing4) By End-user: Academic And Research Institutes; Pharmaceutical And Biotechnology CompaniesCovering: Thermo Fisher Scientific Inc.; Merck KGaA; Charles River Laboratories International Inc.; Lonza Group AG; Catalent Inc. Cell & Gene Therapy ... Read More
-
Translational Regenerative Medicine Market by Product Type (Cell Based Product, Gene Therapy Product, Tissue Engineered Product), Application (Cardiovascular, Dermatology, Diabetes) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 3.36 billion in 2024, at a CAGR 11.48% to reach USD 6.46 billion by 2030. Global Translational Regenerative Medicine Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Viral Vectors Market by Type (Adeno-associated Viral Vectors, Adenoviral Vectors, Retroviral Vectors), Disease (Cancers, Genetic Disorders, Infectious Diseases), Application, End User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 1.88 billion in 2024, at a CAGR 14.09% to reach USD 4.18 billion by 2030. Global Viral Vectors Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Cell & Gene Therapy Drug Delivery Devices Market by Products (Extension Tube, Infusion Bags, Intravenous Catheter), Commercialized Drugs (Kymriah, Luxturna, Provenge) - Global Forecast 2024-2030
... was estimated at USD 1.08 billion in 2023 and expected to reach USD 1.17 billion in 2024, at a CAGR 9.78% to reach USD 2.08 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Cell & Gene Therapy Market by Product (Cell Therapy, Gene Therapy), Delivery Method (Ex Vivo, In Vivo), Application, End-User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 34.63 billion in 2024, at a CAGR 25.39% to reach USD 135.04 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Cancer Gene Therapy Market by Therapy (Gene Induced Immunotherapy, Gene Transfer, Oncolytic Virotherapy), Indication (Breast Cancer, Liver Cancer, Lung Cancer), End-Use - Global Forecast 2024-2030
... 2.20 billion in 2023 and expected to reach USD 2.75 billion in 2024, at a CAGR 20.22% to reach USD 7.99 billion by 2030. Global Cancer Gene Therapy Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Advanced Therapy Medicinal Products CDMO Market by Products (Cell Therapy, Gene Therapy, Tissue Engineered), Phase (Phase I, Phase II, Phase III), Indication, End-Users - Global Forecast 2024-2030
... was estimated at USD 7.54 billion in 2023 and expected to reach USD 8.74 billion in 2024, at a CAGR 17.06% to reach USD 22.74 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Global Forecast 2024-2030
... USD 24.01 billion in 2023 and expected to reach USD 28.82 billion in 2024, at a CAGR 20.13% to reach USD 86.73 billion by 2030. Global Regenerative Medicine Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Viral Vector Manufacturing Market by Type (Adeno-associated Viral Vectors, Adenoviral Vectors, Lentiviral Vectors), Disease (Cancer, Genetic Disorders, Infectious Diseases), Application - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 1.25 billion in 2024, at a CAGR 19.11% to reach USD 3.59 billion by 2030. Global Viral Vector Manufacturing Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Oncology Precision Medicine Market by Type (Cell & Gene Therapy, Inhibitor drugs, Monoclonal Antibodies), Cancer Type (Breast Cancer, Cervical Cancer, Colorectal Cancer), End-use - Global Forecast 2024-2030
... at USD 7.34 billion in 2023 and expected to reach USD 7.67 billion in 2024, at a CAGR 9.10% to reach USD 13.51 billion by 2030. Global Oncology Precision Medicine Market FPNV Positioning Matrix The ... Read More
-
Cell & Gene Therapy Clinical Trials Market by Phase (Phase I, Phase II, Phase III), Application (Cardiology, CNS, Dermatology) - Global Forecast 2024-2030
... USD 6.67 billion in 2023 and expected to reach USD 7.53 billion in 2024, at a CAGR 13.36% to reach USD 16.05 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Gene Cloning Services Market by Service (Custom Cloning Service, Gene Synthesis Service, Molecular Biology Service), Application (Gene Expression, Gene Synthesis, Gene Therapy), End User - Global Forecast 2024-2030
... estimated at USD 2.38 billion in 2023 and expected to reach USD 2.63 billion in 2024, at a CAGR 11.96% to reach USD 5.25 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Brain Tumor Therapeutics Market by Type (Glioblastoma, Meningioma, Metastatic Brain Tumors), Therapy (Chemotherapy, Gene Therapy, Immunotherapy), Patient Age Group, Distribution Channel, End-User - Global Forecast 2024-2030
... USD 3.03 billion in 2023 and expected to reach USD 3.28 billion in 2024, at a CAGR 8.24% to reach USD 5.28 billion by 2030. Global Brain Tumor Therapeutics Market FPNV Positioning Matrix The FPNV ... Read More
-
Bladder Cancer Therapeutics Market by Treatment Type (Chemotherapy, Gene Therapy, Immunotherapy), Bladder Cancer Type (Invasive Bladder Cancer, Squamous Cell Bladder Cancer, Superficial Bladder Cancer), End-User - Global Forecast 2024-2030
... was estimated at USD 5.21 billion in 2023 and expected to reach USD 5.56 billion in 2024, at a CAGR 7.23% to reach USD 8.49 billion by 2030. Global Bladder Cancer Therapeutics Market FPNV Positioning ... Read More
-
Cell & Gene Therapy Biomanufacturing CDMO Market by Component (Cell Therapy, Plasmid DNA, Viral Vector), Phase (Phase 1, Phase 2, Phase 3), Indication - Global Forecast 2024-2030
... size was estimated at USD 338.12 million in 2023 and expected to reach USD 485.47 million in 2024, at a CAGR 32.53% to reach USD 2,428.90 million by 2030. FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Cell and Gene Therapy Manufacturing Market Report: Trends, Forecast and Competitive Analysis to 2030
... with opportunities in the pharmaceutical & biotechnology company and academic & research institute markets. The global cell and gene therapy manufacturing market is expected to reach an estimated $19.1 billion by 2030 with a CAGR ... Read More
-
Global Cell and Gene Therapy Manufacturing Services Market Research Report 2024(Status and Outlook)
... outside of the body (ex vivo). The Global Cell and Gene Therapy Manufacturing Services Market Size was estimated at USD 5193.18 million in 2023 and is projected to reach USD 8661.65 million by 2029, exhibiting ... Read More
-
Global Gene Therapy Market Research Report 2024(Status and Outlook)
... therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier ... Read More
-
Global Human Gene Therapy Market Research Report 2024(Status and Outlook)
... a disorder by altering a person's genetic makeup instead of using drugs or surgery. The Global Human Gene Therapy Market Size was estimated at USD 5383.35 million in 2023 and is projected to reach USD ... Read More
-
Global Drug Based on Gene Therapy Market Research Report 2024(Status and Outlook)
... doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery. The Global Drug Based on Gene Therapy Market Size was estimated at USD 2114.22 million in ... Read More
-
Global Gene Therapy On Cardiovascular Disease Market Research Report 2024(Status and Outlook)
... doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery. Although several conventional small-molecule treatments are available for common cardiovascular problems, gene therapy is a potential ... Read More
-
Global Nucleic Acid Based Gene Therapy Market Research Report 2024(Status and Outlook)
... treat genetic disorders and diseases for which there exists no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia. The Global Nucleic Acid Based Gene Therapy Market Size was estimated at USD ... Read More
-
Rare Hemophilia Factors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
... the forecast period with a CAGR of 5.54% through 2028. The Global Rare Hemophilia Factors Market is a dynamic and vital sector within the broader healthcare industry, focused on addressing the unique needs of individuals ... Read More
Research Assistance
